1. Home
  2. BCRX vs MHD Comparison

BCRX vs MHD Comparison

Compare BCRX & MHD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BioCryst Pharmaceuticals Inc.

BCRX

BioCryst Pharmaceuticals Inc.

SELL

Current Price

$7.63

Market Cap

2.0B

Sector

Health Care

ML Signal

SELL

Logo Blackrock MuniHoldings Fund Inc.

MHD

Blackrock MuniHoldings Fund Inc.

SELL

Current Price

$10.79

Market Cap

1.8B

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
BCRX
MHD
Founded
1986
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Investment Bankers/Brokers/Service
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.8B
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
BCRX
MHD
Price
$7.63
$10.79
Analyst Decision
Buy
Analyst Count
11
0
Target Price
★ $20.55
N/A
AVG Volume (30 Days)
★ 5.1M
1.0M
Earning Date
11-04-2026
01-01-0001
Dividend Yield
N/A
★ 4.16%
EPS Growth
★ 381.40
N/A
EPS
N/A
★ N/A
Revenue
★ $25,186,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3.71
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$6.23
$9.98
52 Week High
$11.22
$12.08

Technical Indicators

Market Signals
Indicator
BCRX
MHD
Relative Strength Index (RSI) 49.24 62.49
Support Level $7.95 $10.67
Resistance Level $9.22 $11.84
Average True Range (ATR) 0.33 0.14
MACD 0.08 0.07
Stochastic Oscillator 53.73 99.98

Price Performance

Historical Comparison
BCRX
MHD

About BCRX BioCryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

About MHD Blackrock MuniHoldings Fund Inc.

Blackrock Muniholdings Fund Inc is a diversified, closed-end management investment company. Its investment objective is to provide shareholders with current income exempt from U.S. federal income taxes. The fund mainly invests its managed assets in municipal bonds rated investment grade or, if unrated, are deemed to be of comparable quality by the investment adviser at the time of investment. Its investment portfolio is mainly comprised of long-term municipal bonds with a maturity of more than ten years at the time of investment. The fund can also invest directly in such securities or synthetically through the use of derivatives.

Share on Social Networks: